Skip to main content
Watch Insiders
Market intelligence
ASNDSector not reported

Ascendis Pharma A/S - ADR insider activity

In the last 90 days, 2 corporate insiders purchased $284,413 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$284,413
Corporate buyers
2
Latest transaction
Jun 2, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 2, 2026Scott Thomas SmithEVP & Chief Financial OfficerOpen Market Purchase100$219.00$21,900
May 29, 2026Jean Jacques BienaimeDirectorOpen Market Purchase500$223.12$111,562
May 29, 2026Scott Thomas SmithEVP & Chief Financial OfficerOpen Market Purchase250$223.32$55,830
Subscribe to see more data